Aquestive Therapeutics

Aquestive Therapeutics

Drug Manufacturers - Specialty & Generic
Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Suboxone, Emylif, Ondif and Sympazan. The product pipeline includes Libervant Buccal Film, AQST-108. The majority of its revenue comes from the United States.

$328.8M

Market Cap • 6/30/2025

2017

(8 years)

Founded

2018

(7 years ago)

IPO

NASDAQ

Listing Exchange

Flag of US

Warren

Headquarters • New Jersey